Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
hypothesis glutathione persister cells

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic

JCI Insight Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis Persister cancer cells: Iron addiction and vulnerability to ferroptosis: Molecular Cell JCI CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione GPX4 Targeted therapy for drug tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours British Journal of Cancer Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect

SKU: 79355347312 · From metron-ms.com

4.9
USD27.52 USD63.52

Pay in 4 interest-free payments of $6.88 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

From the sourcing for raw ingredients to quality control labs in our US manufacturing facilities, we maintain one of the most comprehensive safety and quality assurance programs in the industry

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic

Ruvolo P, Ma H, Ruvolo V, Mu H, Shober W, Yasuhiro T, Yoshizawa T, Gallardo M, Zhang X, Khoury JD, Cortex JE, Andreeff M , Post SM

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic

+ Chng oxy ha ca c th v lm chm qu trnh lo ha

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic

The present investigation demonstrated that in rats given DOX, serum levels of E2 hormone secreted by the ovaries showed a significant decrease

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic

Preparation of GSSG standard solution Mix 100 l of 100 mol/l GSSG standard solution and 300 l of 0.5% SSA solution in a microtube to prepare a 25 mol/l GSSG standard solutions

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products